Diffuse alveolar hemorrhage syndromes

Current Opinion in Rheumatology

Volumn 13, Issue 1, 2001, Pages 12-17

  Specks, Ulrich ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; NEUTROPHIL CYTOPLASMIC ANTIBODY; TOXIN;

ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ENDOSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LUNG HEMORRHAGE; MEDICAL LITERATURE; PATHOGENESIS; PRIORITY JOURNAL; SEROLOGY; SURVIVAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIPHOSPHOLIPID SYNDROME; DIAGNOSIS, DIFFERENTIAL; HEMOPTYSIS; HEMOSIDEROSIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PULMONARY ALVEOLI; SEROLOGIC TESTS; VASCULITIS;

EID: 0035168199     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200101000-00003     Document Type: Article

References (84)

1. Diffuse alveolar hemorrhage following administration of tirofiban or abciximab: A nemesis of platelet glycoprotein IIb/IIla inhibitors
2. Fatal alveolar hemorrhage and Abciximab (ReoPro) therapy for acute myocardial infarction
3. Pulmonary parenchymal manifestations of mitral valve disease
4. Structure, strength, failure, and remodeling of the pulmonary blood-gas barrier
5. Diffuse alveolar hemorrhage syndrome due to 'silent' mitral valve regurgitation
6. Acute autoimmune response in a case of pyromellitic acid dianhydride-induced hemorrhagic alveolitis
7. Immunologic hemorrhagic pneumonia caused by isocyanates
8. Pulmonary haemorrhage and haemolytic anaemia due to trimellitic anhydride
9. Hematologic aspects of end-stage renal failure
10. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation
11. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition
12. Pulmonary capillaritis and diffuse alveolar hemorrhage: A primary manifestation of polymyositis
13. Fatal alveolar hemorrhage in a patient with mixed connective tissue disease presenting polymyositis features
14. Diffuse alveolar hemorrhage in the antiphospolipid syndrome: Spectrum of disease and treatment
15. Idiopathic pulmonary hemosiderosis
16. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease
17. Systemic vasculitis associated with long-term phenytoin therapy
18. Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome
19. Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody
20. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil
21. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: Prevalence among patients with high titers of antimyeloperoxidase antibodies
22. Microangiitis in lupus-induced pulmonary hemorrhage
23. Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome
24. Diffuse alveolar hemorrhage and systemic lupus erythematosus: Clinical presentation, histology, survival, and outcome
25. Adult respiratory distress syndrome in systemic lupus erythematosus: Causes and prognostic factors: A single center, retrospective study
26. Crack lung: An acute pulmonary syndrome with a spectrum of clinical and histopathologic findings
27. Pulmonary histopathology in cocaine abusers
28. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study
29. Autopsy findings in umbilical cord blood transplant recipients
30. Pulmonary complications in lymphoma patients treated with high-dose therapy autologous bone marrow transplantation
31. Diffuse pulmonary lymphangiomatosis
32. Death due to diffuse alveolar hemorrhage in a child with pulmonary veno-occlusive disease
33. Pulmonary capillary hemangiomatosis
34. Angiosarcoma presenting as diffuse alveolar hemorrhage
35. Pulmonary haemorrhage in Oriental patients with systemic lupus erythematosus
36. Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide
37. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus
38. Randomized controlled trial of pulse/synchronization cyclophosphamide/apheresis for proliferative lupus nephritis
39. Catastrophic antiphospholipid syndrome: Clinical and laboratory features of 50 patients
40. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome
41. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis
42. Pulmonary haemorrhage and focal necrotizing glomerulonephritis in a case of systemic sclerosis
43. Diffuse alveolar-hemorrhage in limited cutaneous systemic sclerosis with positive perinuclear anti-neutrophil cytoplasmic antibodies
44. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis
45. Characterization of anti-GBM antibodies involved in Goodpasture's syndrome
46. Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease
47. Distribution of Goodpasture antigens within various human basement membranes
48. Anti-GBM disease: Predictive value of clinical, histological and serological data
49. Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome
50. Plasmapheresis and immunoadsorption: Different techniques and their current role in medical therapy
51. Anti-neutrophil cytoplasm antibodies and anti-glomecular basement membrane antibodies: Two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis
52. Comparison of anti-GBM antibodies in sera with or without ANCA
53. Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis
54. Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in anti-glomerular basement membrane disease
55. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis
56. Anti-neutrophil cytoplasm antibodies, anti-GBM antibodies and anti-dsDNA antibodies in glomerulonephritis
57. Coexistent anti-neutrophil cytoplasmic antibody and antiglomerular basement membrane antibody associated disease: Report of six cases
58. Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease
59. Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis
60. Wegener granulomatosis: An analysis of 158 patients
61. Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients
62. Churg-Strauss syndrome presenting with pulmonary capillaritis and diffuse alveolar hemorrhage
63. Churg-Strauss syndrome: Clinical study and long-term follow-up of 96 patients
64. Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis
65. Microscopic polyangiitis with alveolar hemorrhage: A study of 29 cases and review of the literature
66. Subclinical alveolar bleeding in pulmonary vasculitides: Correlation with indices of disease activity
67. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization
68. Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies
69. Antimyeloperoxidase autoantibody-associated necrotizing alveolar capillaritis
70. Plasma exchange treatment in rapidly progressive glomerulonephritis associated with anti-neutrophil cytoplasmic autoantibodies
71. Disease spectrum of patients with antineutrophil cytoplasmic autoantibodies of defined specificity: Distinct differences between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies
72. Differences between anti-myeloperoxidase and anti-proteinase 3-associated renal disease
73. In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis
74. Pulmonary disease in Behçet's syndrome
75. A case of pulmonary hemorrhage in Henoch-Schonlein purpura accompanied by polyarteritis nodosa in an elderly man
76. Alveolar hemorrhage in IgA nephropathy treated with plasmapheresis
77. Pulmonary hemorrhage. A fatal manifestation in IgA nephropathy
78. Diffuse recidivant alveolar hemorrhage in a patient with hepatitis C virus-related mixed cryoglobulinemia
79. Progressive massive fibrosis associated with idiopathic pulmonary hemosiderosis
80. Long-term clinical course of patients with idiopathic pulmonary hemosiderosis (1979-1994): Prolonged survival with low-dose corticosteroid therapy
81. Idiopathic pulmonary hemosiderosis: Ultrastructural studies and responses to azathioprine
82. Effectiveness of chloroquine therapy in idiopathic pulmonary hemosiderosis
83. Idiopathic pulmonary hemosiderosis, complete heart block and celiac disease
84. Long-term clinical follow-up of adult idiopathic pulmonary hemosiderosis and celiac disease